5. 2) giver ikke grund til at anvende et forskelligt start- regimen eller forskellige dosistitreringstrin for at opnå et behandlingsregimen med anagrelid, der er optimalt for den enkelte patient.
2 Elderly The observed pharmacokinetic differences between elderly and young patients with ET (see section 5.2) do not warrant using a different starting regimen or different dose titration step to achieve an individual patient-optimised anagrelide regimen.